Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 07, 2026
Monster Beverage (MNST) Delivers Record Q2 Results with +20.2% Revenue Growth

Monster Beverage (MNST) Delivers Record Q2 Results with +20.2% Revenue Growth

Key Takeaways

  • Revenue beat: Net sales surged 20.2% year-over-year to a record $2.54 billion, surpassing the consensus estimate of $2.42 billion.
  • Earnings exceeded expectations: Non-GAAP (adjusted) diluted earnings per share came in at $0.60, $0.02 above the analyst consensus of $0.58.
  • International momentum: Sales to customers outside the United States jumped 34.6% to $1.16 billion, now representing approximately 46% of total net sales.
  • Gross margin held firm: Gross profit as a percentage of net sales edged up to 55.9% from 55.7% a year ago, supported by pricing actions and product mix.
  • Alcohol segment continued to drag: Alcohol Brands segment net sales declined 15.2% year-over-year to $32.2 million.
  • Stock split announced: The company declared a 2-for-1 stock split effective August 11, 2026, signaling management confidence in ongoing momentum.

Earnings Context and Why It Matters

Monster Beverage entered its second quarter 2026 earnings report with considerable momentum. In the first quarter, the company delivered net sales growth of 26.9% year-over-year and an earnings beat of $0.05 per share. Heading into the Q2 release, analysts had projected continued double-digit growth, with consensus estimates calling for approximately $0.58 in earnings per share on revenue of $2.42 billion. With the stock trading at a forward P/E above 40 and near its 52-week high of $100.34, investors were focused on whether Monster's product innovation engine and international expansion through its Coca-Cola distribution partnership could sustain growth at a pace that justifies its premium valuation. The report also carried broader significance for the consumer staples sector, offering a read on global energy drink demand trends, consumer spending resilience, and the effectiveness of recent pricing actions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

Monster Beverage reported second quarter net sales of $2.54 billion, a 20.2% increase from $2.11 billion in the same period last year and approximately $120 million above the consensus estimate. This marked the first time in the company's history that quarterly net sales crossed the $2.5 billion threshold. Foreign currency exchange rates provided a favorable tailwind of $48.5 million; on a currency-adjusted basis, net sales rose 17.9%.

On the bottom line, GAAP net income increased 19.6% to $584.5 million, or $0.59 per diluted share, compared to $488.8 million, or $0.50 per share, in the prior-year quarter. On a non-GAAP adjusted basis, net income per diluted share was $0.60, exceeding the analyst consensus of $0.58.

The company's core Monster Energy Drinks segment delivered standout performance, with net sales rising 21.6% to $2.36 billion. Strategic Brands, which includes energy drink brands acquired from The Coca-Cola Company as well as affordable offerings Predator and Fury, grew 10.6% to $143.7 million. The Alcohol Brands segment continued to weaken, declining 15.2% to $32.2 million. International sales represented a bright spot, climbing 34.6% to $1.16 billion and accounting for roughly 46% of total reported net sales, up from 41% a year earlier.

Gross profit as a percentage of net sales improved marginally to 55.9% from 55.7%, reflecting pricing actions and favorable product sales mix, partially offset by higher aluminum can costs and increased freight-in expenses. Operating income rose 17.2% to $740.4 million. Operating expenses as a percentage of net sales increased to 26.8% from 25.8%, driven by higher marketing, sponsorship, and digital media spending aimed at broadening consumer reach. From what I see, the international numbers stand out as a key driver here.

Market Reaction and Investor Sentiment

Monster Beverage shares closed the regular trading session on August 6 at $94.16, down 0.32% on the day, before moving modestly higher in after-hours trading to approximately $94.70. The relatively muted price response, despite a clean beat on both revenue and earnings, suggests the market had largely priced in a strong quarter. With the stock already up approximately 55% over the prior twelve months and trading near its 52-week high, the results—while solid—did not provide the kind of upside surprise needed to drive a significant re-rating. Investor sentiment appeared to balance enthusiasm for record revenue and sustained international growth against concerns about rising operating expenses, modest gross margin pressure from aluminum costs, and a valuation that leaves limited room for disappointment. The announced 2-for-1 stock split was viewed as a positive signal of management's confidence in the business trajectory.

Forward Outlook and Key Factors to Monitor

Looking ahead, several factors will shape Monster Beverage's trajectory through the remainder of 2026 and into 2027. Management disclosed that July 2026 sales were up approximately 14% year-over-year, indicating continued healthy demand exiting the second quarter, albeit at a moderating pace from the 20.2% growth posted in Q2.

On the pricing front, the company confirmed plans to implement selective price increases in the U.S. during the fourth quarter, building on the mid-single-digit increases introduced in late 2025. Low-single-digit pricing actions are also underway in parts of the EMEA region. These moves will be closely watched for their impact on volume trends as consumers navigate a mixed macroeconomic environment.

Cost management remains a critical area of focus. Management expects aluminum costs to rise modestly through the end of 2026, driven by higher Midwest Premiums linked to tariffs. Combined with elevated freight and fuel expenses, these input cost pressures could continue to test gross margins, even as pricing actions provide a partial offset.

Innovation will remain a central pillar of Monster's growth strategy. The company plans to present its full 2027 innovation calendar at the NACS Show in October, and fall 2026 product launches are already rolling out. The FLRT brand, targeting female consumers, is still in its early stages with additional launches planned. International expansion continues to represent a significant runway, particularly in high-growth markets such as China, India, and Brazil, where Monster is gaining share through its Coca-Cola bottler distribution network. Finally, with approximately $900 million remaining under the existing share repurchase authorization and the upcoming stock split, capital allocation decisions will remain an important signal of management's long-term confidence. I’m watching this closely as the company moves into the back half of the year.

Using AI Tools for Deeper Analysis

In my research process, I regularly turn to Tickeron’s AI Screener to filter stocks by criteria like industry trends, technical setups, and AI-generated signals. It helps me quickly compare names like MNST against peers and spot patterns that complement traditional earnings analysis. The platform streamlines discovery without replacing fundamental review, and I’ve found it especially useful for tracking sector momentum in consumer staples.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MNST

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MNST in +3.01% Uptrend, advancing for three consecutive days on August 24, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MNST advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MNST's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for MNST crossed bullishly above the 50-day moving average on August 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNST as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MNST turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

MNST moved below its 50-day moving average on September 02, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MNST entered a downward trend on August 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MNST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.025) is normal, around the industry mean (5.798). P/E Ratio (39.954) is within average values for comparable stocks, (44.128). Projected Growth (PEG Ratio) (2.219) is also within normal values, averaging (4.074). MNST's Dividend Yield (0.000) is considerably lower than the industry average of (0.026). MNST's P/S Ratio (9.242) is very high in comparison to the industry average of (2.773).

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), PepsiCo (NASDAQ:PEP).

Industry description

Non-alcoholic drinks include traces of alcohol or low alcohol content or without alcohol or alcohol removed. Functional Beverages, Carbonated Soft Drinks (CSDs), Sports Drinks, Fruit Beverages, and Bottled Water are some common types of non-alcoholic beverages. The largest segment in this market is soft drinks (think Pepsi and Coke). Many established companies in this space have also been stepping up production of low to zero-calorie varieties in recent years, to cater to a rising number of health-conscious consumers. Coca-Cola Company, Pepsico Inc, Keurig Dr Pepper Inc. and Monster Beverage Corporation are some major non-alcoholic beverage makers.

Market Cap

The average market capitalization across the Beverages: Non-Alcoholic Industry is 47.2B. The market cap for tickers in the group ranges from 1.77K to 380.17B. KO holds the highest valuation in this group at 380.17B. The lowest valued company is BVNNF at 1.77K.

High and low price notable news

The average weekly price growth across all stocks in the Beverages: Non-Alcoholic Industry was -3%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was -13%. BNKK experienced the highest price growth at 20%, while COCO experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Beverages: Non-Alcoholic Industry was 15%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 61
Price Growth Rating: 55
SMR Rating: 65
Profit Risk Rating: 74
Seasonality Score: -41 (-100 ... +100)
View a ticker or compare two or three
MNST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company with interests in markets and distributes energy drinks

Industry BeveragesNonAlcoholic

Profile
Details
Industry
Beverages Non Alcoholic
Address
1 Monster Way
Phone
+1 951 739-6200
Employees
6891
Web
https://www.monsterbevcorp.com
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.